[1]
Adehi, M.U. et al. 2025. HETEROGENEITY IN CANCER RISK ASSOCIATED WITH ANTIHYPERTENSIVE DRUG USE: A META-ANALYSIS OF LOSARTAN AND AMLODIPINE. Economics and Statistics Research Journal (ESRJ). 16, 7 (Jul. 2025), 30–43. DOI:https://doi.org/10.5281/zenodo.16099289.